<table id="id_f4730ab8-a095-4fa8-a708-473de69a1bb3" width="430.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_72226b89-93ab-4cd5-b3e4-b743ec316cea">AZITHROMYCIN CONCENTRATIONS FOLLOWING A 500 mg DOSE (TWO 250 mg CAPSULES) IN ADULTS<footnote id="id-4584af73-4e01-4909-9a31-ddf2b6c199ba">Azithromycin tissue concentrations were originally determined using 250 mg capsules.</footnote>
</caption>
<col align="left" width="20.0%"></col>
<col align="center" width="20.0%"></col>
<col align="center" width="20.0%"></col>
<col align="center" width="20.0%"></col>
<col align="center" width="20.0%"></col>
<thead>
<tr id="id_679ae154-4cbf-4165-aefb-a1e07c4ce28f" stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top">TISSUE OR FLUID</td>
<td align="left" stylecode="Rrule" valign="top"> TIME AFTER DOSE (h)</td>
<td align="left" stylecode="Rrule" valign="top">TISSUE OR FLUID CONCENTRATION<br/>(µg/g or µg/mL)</td>
<td align="left" stylecode="Rrule" valign="top">CORRESPONDING<br/>PLASMA OR SERUM<br/>LEVEL (µg/mL)</td>
<td align="left" stylecode="Rrule" valign="top">
<content stylecode="underline">TISSUE (FLUID)</content>
<br/>PLASMA (SERUM)<br/>RATIO</td>
</tr>
</thead>
<tbody>
<tr id="id_7c9b0bcc-9c79-4f3b-8d50-c7053be38a34" stylecode="Toprule">
<td align="left" stylecode="Lrule" valign="top">SKIN</td>
<td align="left" stylecode="Toprule" valign="top">72–96</td>
<td align="left" stylecode="Toprule" valign="top">0.4</td>
<td align="left" stylecode="Toprule" valign="top">0.012</td>
<td align="left" stylecode="Rrule" valign="top">35</td>
</tr>
<tr id="id_b3bf77d1-7a7f-46cf-8a08-59b3ef79582e">
<td align="left" stylecode="Lrule" valign="top">LUNG</td>
<td align="left" valign="top">72–96</td>
<td align="left" valign="top">4.0</td>
<td align="left" valign="top">0.012</td>
<td align="left" stylecode="Rrule" valign="top">&gt;100</td>
</tr>
<tr id="id_c788c1e4-4c71-4068-931c-0a9c987cbeeb">
<td align="left" stylecode="Lrule" valign="top">SPUTUM<footnote id="id-bceeda4f-24d9-4fd6-9f83-ef30ac846451">Sample was obtained 2–4 hours after the first dose.</footnote>
</td>
<td align="left" valign="top">2–4</td>
<td align="left" valign="top">1.0</td>
<td align="left" valign="top">0.64</td>
<td align="left" stylecode="Rrule" valign="top">      2</td>
</tr>
<tr id="id_5427fc3b-32db-46d4-8bef-d70cf8dd3df1">
<td align="left" stylecode="Lrule" valign="top">SPUTUM<footnote id="id-756f2b12-e9d6-4371-a599-b330bbfaba57">Sample was obtained 10–12 hours after the first dose.</footnote>
</td>
<td align="left" valign="top">10–12</td>
<td align="left" valign="top">2.9</td>
<td align="left" valign="top">0.1</td>
<td align="left" stylecode="Rrule" valign="top">    30</td>
</tr>
<tr id="id_b370d661-d8f5-46d2-99fc-65d84256010b">
<td align="left" stylecode="Lrule" valign="top">TONSIL<footnote id="id-2f6b5fb1-d4e6-45e6-a754-6f9be1a4471f">Dosing regimen of two doses of 250 mg each, separated by 12 hours.</footnote>
</td>
<td align="left" valign="top">9–18</td>
<td align="left" valign="top">4.5</td>
<td align="left" valign="top">0.03</td>
<td align="left" stylecode="Rrule" valign="top">&gt;100</td>
</tr>
<tr id="id_a43719a2-e497-48a2-a42f-a67fb592bc6b">
<td align="left" stylecode="Lrule" valign="top">TONSIL<footnoteref idref="id-2f6b5fb1-d4e6-45e6-a754-6f9be1a4471f"></footnoteref>
</td>
<td align="left" valign="top">180</td>
<td align="left" valign="top">0.9</td>
<td align="left" valign="top">0.006</td>
<td align="left" stylecode="Rrule" valign="top">&gt;100</td>
</tr>
<tr id="id_89fc80f5-eef4-4efe-addf-0ba7211551fe" stylecode="Botrule">
<td align="left" stylecode="Lrule" valign="top">CERVIX<footnote id="id-a70851c2-24af-4060-846c-4628ec114066">Sample was obtained 19 hours after a single 500 mg dose.</footnote>
</td>
<td align="left" valign="top">19</td>
<td align="left" valign="top">2.8</td>
<td align="left" valign="top">0.04</td>
<td align="left" stylecode="Rrule" valign="top">    70</td>
</tr>
</tbody>
</table>